1
Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer Patients
Condition(s): Breast Cancer Last Updated: April 17, 2013Completed
13 Clinical Trials for: Oncotype, Page 1 of 1
Hide Studies Not Seeking New Volunteers
2
A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer
Condition(s): Breast Cancer Last Updated: May 1, 2013Recruiting
3
"Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"
Condition(s): Infiltrating Duct and Lobular Carcinoma In Situ; Invasive Lobular Breast Carcinoma; Inflammatory Breast Carcinoma Last Updated: July 12, 2012Recruiting
4
Correlation Between Fluorodeoxyglucose (FDG) and FLT Uptake and Gene-Expression Oncotype Assay in Patients With Breast Cancer
Condition(s): Breast Cancer Last Updated: May 30, 2008Not yet recruiting
5
Studying Tumor Tissue Samples From Patients With Early-Stage Breast Cancer
Condition(s): Breast Cancer Last Updated: February 1, 2011Completed
6
PET-Guided Chemotherapy and Hormone Therapy in Treating Women With Previously Untreated Invasive Breast Cancer
Condition(s): Breast Cancer Last Updated: April 12, 2011Recruiting
7
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Condition(s): Estrogen Receptor-positive Breast Cancer; HER2-negative Breast Cancer; Progesterone Receptor-positive Breast Cancer; Stage IA Breast Cancer; Stage IB Breast Cancer; Stage II Breast Cancer; Stage IIIB Breast Cancer Last Updated: April 9, 2013Active, not recruiting
8
Knowledge and Attitudes of Patients and Healthcare Professionals on a Spectrum of Genetic Tests Relevant to Breast Cancer Patients
Condition(s): Breast Cancer Last Updated: June 12, 2012Recruiting
9
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Condition(s): Hormone Receptor Positive Malignant Neoplasm of Breast Last Updated: April 18, 2013Recruiting
10
Ixabepilone and Cyclophophamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer
Condition(s): Breast Cancer Last Updated: June 5, 2012Active, not recruiting
11
Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer
Condition(s): Breast Cancer; Breast Cancer Stage II-III Last Updated: May 5, 2012Recruiting
12
Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer
Condition(s): Ductal Breast Carcinoma in Situ; Lobular Breast Carcinoma in Situ; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer Last Updated: May 16, 2013Recruiting
13
Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.
Condition(s): Invasive Breast Cancer Last Updated: May 15, 2013Recruiting
